The c-Abl inhibitor, radotinib induces apoptosis in multiple myeloma cells via mitochondrial-dependent pathway
Abstract Multiple myeloma (MM) is a hematological cancer resulting from accumulated abnormal plasma cells. Unfortunately, MM remains an incurable disease, as relapse is very common. Therefore, there is urgent need to develop new treatment options for MM. Radotinib is a novel anti-cancer drug, curren...
Enregistré dans:
Auteurs principaux: | Sook-Kyoung Heo, Eui-Kyu Noh, Jeong Yi Kim, Ho-Min Yu, Jun Young Sung, Lan Jeong Ju, Do Kyoung Kim, Hye Jin Seo, Yoo Jin Lee, Jaekyung Cheon, SuJin Koh, Young Joo Min, Yunsuk Choi, Jae-Cheol Jo |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/43d427a0131f4e40b71f116b3d316acb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Author Correction: Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death
par: Sook-Kyoung Heo, et autres
Publié: (2021) -
Multi-directionally wrinkle-able textile OLEDs for clothing-type displays
par: Seungyeop Choi, et autres
Publié: (2020) -
Relationship between chronic exposure to ambient air pollution and mental health in Korean adult cancer survivors and the general population
par: Hyun-Jin Kim, et autres
Publié: (2021) -
Adverse outcomes after surgeries in patients with liver cirrhosis among Korean population: A population-based study.
par: Hyun Ho Jo, et autres
Publié: (2021) -
Strong association of type 2 diabetes with degenerative lumbar spine disorders
par: Chul-Hyun Park, et autres
Publié: (2021)